Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 66–66 | Cite as

Bevacizumab

Various toxicities: 5 case reports
Case report
  • 26 Downloads

Reference

  1. Romera A, et al. Implementing a treatment registry for a biosimilar: Continuous safety surveillance of the biosimilar Bevax (bevacizumab) in Argentina. GaBI Journal 7: 111-120, No. 3, Jan 2018. Available from: URL: http://doi.org/10.5639/gabij.2018.0703.023 - ArgentinaCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations